Table 3

Characteristics of confirmed ICI enterocolitis cases

CharacteristicN%
Confirmed ICI enterocolitis8057.97
Time from first ICI dose to symptom onset (days)
 Median74
 IQR40–160
Time from symptom onset to resolution (days)
 Median25
 IQR13–50
CTCAE grade of enterocolitis
 Grade 000.00
 Grade 167.50
 Grade 21822.50
 Grade 34252.50
 Grade 41215.00
 Grade 522.50
Treatment
 PO steroids1215.00
 Intravenous steroids6176.25
 Infliximab3240.00
 Vedolizumab56.25
 Antibiotics45.00
 Other*810.00
  • *Other treatments: budesonide (4), cholestyramine (3), abatacept (2), omeprazole (1).

  • CTCAE, Common Terminology Criteria for Adverse Events; ICI, immune checkpoint inhibitor; PO, per os.